Author summary Why was this study done? Drug resistance poses a major barrier to the effective treatment of tuberculosis, especially in Moldova and other post-Soviet states which have the highest levels of resistance in the world. Individuals with tuberculosis resistant to the key drug rifampicin face a worse prognosis, a longer and more expensive course of treatment, and more side effects than individuals with rifampicin-susceptible tuberculosis. Until recently, the standard of care for rifampicin-resistant tuberculosis (RR-TB) involved many drugs in combination, often given for 18 months or longer. The newer, 6-month “BPaLM” regimen is comprised of 4 drugs (bedaquiline, pretomanid, linezolid, and moxifloxacin) to which resistance levels are currently low, and while it was shown to be just as effective as the standard of care when health outcomes were measured at 72 weeks from treatment initiation, its effect on lifetime health outcomes, costs, and the acquisition of dru
Although Moldovan President Maia Sandu has been regarded as the most pro-Western and EU-enthusiastic leader of the country promising to add a referendum on accession to the European Union to the upcoming presidential elections there are several warning signs regarding the government’s conduct that the European community, and indeed Moldovans, should heed. - writes Admir Lisica . Framing Moldova’s EU membership […]
Peace Winds Moldova invites interested companies to submit their proposals for Rehabilitation of two educational institutions in Chisinau civic.md - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from civic.md Daily Mail and Mail on Sunday newspapers.
Ramp Expands Global Crypto On-Ramp Service with Additional 40 Currencies webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.